A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
Nadine Rouphale, the executive director and professor of vaccinology and infectious diseases at Emory University, spoke about her work on Tuesday at the Lehman Auditorium in the Science and ...